Synopsys delivers 16.68% annual return over 20 years

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Synopsys has outperformed the market over the last 20 years with an average annual return of 16.68%, beating the market by 7.45% annually. A $1000 investment made two decades ago would be worth $22,169.23 today, highlighting the impact of compounded returns.

powered bylight_fuzz_icon
46229181

*this image is generated using AI for illustrative purposes only.

Synopsys has generated significant shareholder value over the past two decades, delivering an average annual return of 16.68%. This performance represents a 7.45% annualized outperformance compared to the broader market. The company currently commands a market capitalization of $74.30 billion, reflecting its strong position in the sector.

Investment Growth Analysis

The power of compounded returns is evident when analyzing the long-term trajectory of Synopsys stock. An investor who purchased $1000 worth of shares 20 years ago would see that investment grow substantially by today.

Metric Value
Initial Investment $1000
Current Value $22,169.23
Current Share Price $388.01
Average Annual Return 16.68%
Market Outperformance 7.45%

Key Takeaways

The primary insight from this 20-year review is the substantial impact that compounded returns can have on capital growth over extended periods. Synopsys has consistently provided returns that exceed market averages, translating into significant wealth accumulation for long-term stakeholders.

Can Synopsys sustain its historical 16.68% annual return given current market saturation and competition?

How might recent advancements in AI impact Synopsys' future growth trajectory and market position?

What are the key risks that could derail Synopsys' continued outperformance over the broader market?

like19
dislike

Synopsys tests critical $385 support level amid decline

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Synopsys, Inc. shares are trading lower Monday but are testing a significant support level at $385. This price point has acted as both resistance and support historically, suggesting a large move may be imminent.

powered bylight_fuzz_icon
46120674

*this image is generated using AI for illustrative purposes only.

Synopsys, Inc. (NASDAQ: SNPS) shares are trading lower Monday, testing a critical price level that could signal a significant market move. The stock is hovering around the $385 mark, a level that has historically served as both resistance and support, making it a focal point for traders analyzing potential trend reversals.

In financial markets, support and resistance levels indicate where large quantities of buy or sell orders exist. At support levels, buy orders typically absorb sell orders, potentially halting a downtrend. Conversely, resistance levels feature sell orders that can cap an uptrend. The $385 level has demonstrated both roles over time.

Historical data shows $385 acted as resistance in December 2021 and August 2022. Resistance often re-emerges at previous levels due to buyers who purchased at the peak and later sell to break even when the price returns. This dynamic creates a concentration of sell orders, reinforcing the resistance.

Date Role Price Level
December 2021 Resistance $385
August 2022 Resistance $385
April 2025 Support $385
September 2025 Support $385
November 2025 Support $385
March 2026 Support $385

The $385 level transitioned to support in April 2025 and held again in September, November, and March of this year. Support levels often re-form due to seller's remorse, where investors who sold too low place buy orders to re-enter at the same price. This activity creates a floor, preventing further declines.

Traders monitor these levels to anticipate trend changes. With Synopsys testing this established support again, market participants are watching for a potential reversal or a breakdown that could signal a new direction.

What technical indicators, other than price history, suggest whether the $385 support will hold or fail?

How might a breakdown below $385 impact Synopsys' long-term institutional investor sentiment?

What upcoming earnings reports or product announcements could act as catalysts for a trend reversal?

like16
dislike

More News on Synopsys Inc